1. Home
  2. SNY
  3. SNY News

Latest Sanofi ADS (SNY) News on September 18, 2025

Sanofi (SNY) Fell on Tariff Uncertainty
SNY

Insider Monkey

13 hours ago

Sanofi (SNY) Fell on Tariff Uncertainty

EADV 25: Sanofi’s brivekimig success in Phase IIa HS trial
SNY

Clinical Trials Arena

15 hours ago

EADV 25: Sanofi’s brivekimig success in Phase IIa HS trial

SNY

Investing.com

19 hours ago

AstraZeneca says Fasenra misses main goal in COPD trial

Press Release: EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a study
SNY

GlobeNewswire

21 hours ago

Press Release: EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a study

SNY

Investing.com

a day ago

Kymera initiated at Outperform on potential of lead skin drug

AllRock Bio Announces $50 Million Series A to Advance Lead Clinical Program for Pulmonary Hypertension
SNY

PR Newswire

2 days ago

AllRock Bio Announces $50 Million Series A to Advance Lead Clinical Program for Pulmonary Hypertension

Senhwa Biosciences' CX-5461 Teams Up with Global PD-1 Leaders to Enter the Immunotherapy Arena, Targeting Multi-Billion Dollar Global Market
SNY

PR Newswire

2 days ago

Senhwa Biosciences' CX-5461 Teams Up with Global PD-1 Leaders to Enter the Immunotherapy Arena, Targeting Multi-Billion Dollar Global Market

Former CinCor execs reunite to helm new biotech startup
SNY

BioPharma Dive

2 days ago

Former CinCor execs reunite to helm new biotech startup

Leerink Partners Maintains a Buy Rating on Sanofi (SNY)
SNY

Insider Monkey

3 days ago

Leerink Partners Maintains a Buy Rating on Sanofi (SNY)

Sanofi: Information concerning the total number of voting rights and shares - August 2025
SNY

GlobeNewswire

5 days ago

Sanofi: Information concerning the total number of voting rights and shares - August 2025

Novartis Catches a ‘Sell.’ Goldman Sachs Says the Stock Is Overvalued.
SNY

Barrons.com

5 days ago

Novartis Catches a ‘Sell.’ Goldman Sachs Says the Stock Is Overvalued.

LB Pharmaceuticals tops 2025 biotech IPO list with $285m Nasdaq debut
SNY

Pharmaceutical Technology

5 days ago

LB Pharmaceuticals tops 2025 biotech IPO list with $285m Nasdaq debut

GTCR to acquire generic drug maker Zentiva
SNY

Pharmaceutical Technology

6 days ago

GTCR to acquire generic drug maker Zentiva

Pfizer Is Growing More Reliant on Vaccines as Controversies Swirl
SNY

Barrons.com

6 days ago

Pfizer Is Growing More Reliant on Vaccines as Controversies Swirl

AMERICAN SKIN ASSOCIATION ANNUAL GALA CELEBRATES OUTSTANDING HONOREES
SNY

PR Newswire

6 days ago

AMERICAN SKIN ASSOCIATION ANNUAL GALA CELEBRATES OUTSTANDING HONOREES

SNY's Gene Therapy Candidate for Eye Disease Gets FDA Fast Track Tag
SNY

Zacks

6 days ago

SNY's Gene Therapy Candidate for Eye Disease Gets FDA Fast Track Tag

Sanofi’s Tzield gains approval in China for T1D management
SNY

Pharmaceutical Technology

7 days ago

Sanofi’s Tzield gains approval in China for T1D management

SNY

MT Newswires

7 days ago

Sanofi Says FDA Granted Fast-Track Designation for Age-Related Macular Degeneration Therapeutic Candidate

Press Release: Sanofi’s SAR402663 earns fast track designation in the US for neovascular age-related macular degeneration
SNY

GlobeNewswire

7 days ago

Press Release: Sanofi’s SAR402663 earns fast track designation in the US for neovascular age-related macular degeneration

Private equity GTCR strikes $4.8 billion deal to buy Zentiva, FT reports
SNY

Reuters

7 days ago

Private equity GTCR strikes $4.8 billion deal to buy Zentiva, FT reports

Mandy Moore and Celebrity Mom Squad join Sanofi to help protect babies from RSV with BEYFORTUS®
SNY

PR Newswire

8 days ago

Mandy Moore and Celebrity Mom Squad join Sanofi to help protect babies from RSV with BEYFORTUS®

Press Release: Tzield approved in China as first disease-modifying therapy for adult and pediatric patients with stage 2 type 1 diabetes
SNY

GlobeNewswire

8 days ago

Press Release: Tzield approved in China as first disease-modifying therapy for adult and pediatric patients with stage 2 type 1 diabetes

Lucem Health announces new initiative to accelerate early detection of Type 1 Diabetes (T1D)
SNY

PR Newswire

9 days ago

Lucem Health announces new initiative to accelerate early detection of Type 1 Diabetes (T1D)

Vyome Holdings Strengthens Leadership Team with Industry Veterans as it plans Pivotal Trial Studies
SNY

Business Wire

9 days ago

Vyome Holdings Strengthens Leadership Team with Industry Veterans as it plans Pivotal Trial Studies

Concussions Market Research Report 2025-2035 | Epidemiological Analysis, Key Market Trends, Patent Analysis, Regulatory Landscape, Pipeline Analysis, Market Dynamics
SNY

GlobeNewswire

9 days ago

Concussions Market Research Report 2025-2035 | Epidemiological Analysis, Key Market Trends, Patent Analysis, Regulatory Landscape, Pipeline Analysis, Market Dynamics

Health Care Roundup: Market Talk
SNY

The Wall Street Journal

9 days ago

Health Care Roundup: Market Talk

Onco360® Has Been Selected as a National Specialty Pharmacy Partner for Wayrilz™ (rilzabrutinib)
SNY

GlobeNewswire

9 days ago

Onco360® Has Been Selected as a National Specialty Pharmacy Partner for Wayrilz™ (rilzabrutinib)

Why Dianthus Therapeutics, Up 47% In Four Weeks, Just Surged Again
SNY

Investor's Business Daily

9 days ago

Why Dianthus Therapeutics, Up 47% In Four Weeks, Just Surged Again

SNY

Business Wire

10 days ago

WPIX-TV to Carry New York Mets Games Through 2028

SNY

Argus Research

10 days ago

Weekly Stock List

SNY

MT Newswires

10 days ago

Morgan Stanley Upgrades Sanofi to Overweight From Equalweight, Price Target is $58

A Look at Sanofi (ENXTPA:SAN) Valuation Following FDA Approval of Breakthrough Rare Disease Therapy
SNY

Simply Wall St.

11 days ago

A Look at Sanofi (ENXTPA:SAN) Valuation Following FDA Approval of Breakthrough Rare Disease Therapy

Sanofi (SNY) Loses 9% as New Drug Candidate Appears Weaker Than Predecessor
SNY

Insider Monkey

12 days ago

Sanofi (SNY) Loses 9% as New Drug Candidate Appears Weaker Than Predecessor

Why Nektar Therapeutics Rippled Higher This Week
SNY

Motley Fool

12 days ago

Why Nektar Therapeutics Rippled Higher This Week

Health Care Roundup: Market Talk
SNY

The Wall Street Journal

13 days ago

Health Care Roundup: Market Talk

Acetaminophen Market Trends and Forecasts, 2023-2024 & 2025-2033 | Rising OTC Demand, Wider Access to Essential Medicines, and Growth in Combination Therapies Drive Expansion
SNY

GlobeNewswire

13 days ago

Acetaminophen Market Trends and Forecasts, 2023-2024 & 2025-2033 | Rising OTC Demand, Wider Access to Essential Medicines, and Growth in Combination Therapies Drive Expansion

Lyophilized Injectable Drugs Market Report 2025-2033 | R&D Efforts to Improve Safety and Reconstitution Time, Alongside Expanding CDMO Services and Emerging Market Contributions
SNY

GlobeNewswire

13 days ago

Lyophilized Injectable Drugs Market Report 2025-2033 | R&D Efforts to Improve Safety and Reconstitution Time, Alongside Expanding CDMO Services and Emerging Market Contributions

Revolut hires former SocGen boss Oudea as West Europe chairman
SNY

Reuters

13 days ago

Revolut hires former SocGen boss Oudea as West Europe chairman

Today's moving stocks: American Eagle, Figma, T. Rowe Price, Amazon, Sanofi
SNY

TheStreet

13 days ago

Today's moving stocks: American Eagle, Figma, T. Rowe Price, Amazon, Sanofi

Sanofi Drops As Eczema Drug Faces Big Test
SNY

GuruFocus.com

13 days ago

Sanofi Drops As Eczema Drug Faces Big Test

SNY

MT Newswires

13 days ago

Sector Update: Health Care Stocks Rise Late Afternoon

Sanofi Tumbles As New Eczema Drug Lags Dupixent's 'Compelling Bar'
SNY

Investor's Business Daily

14 days ago

Sanofi Tumbles As New Eczema Drug Lags Dupixent's 'Compelling Bar'

Sanofi Hit With Shock As Flagship Drug Successor Disappoints Investors
SNY

Benzinga

14 days ago

Sanofi Hit With Shock As Flagship Drug Successor Disappoints Investors

SNY

MT Newswires

14 days ago

Sector Update: Health Care Stocks Steady Premarket Thursday

SNY

MT Newswires

14 days ago

Sector Update: Health Care

SNY

MT Newswires

14 days ago

Sanofi Says Atopic Dermatitis Phase 3 Trial Meets Primary, Key Secondary Endpoints; Shares Down Pre-Bell

Sanofi Shares Sink as Experimental Drug Results Disappoint
SNY

The Wall Street Journal

14 days ago

Sanofi Shares Sink as Experimental Drug Results Disappoint

Sanofi sheds $13 billion in value on weak trial results for eczema drug
SNY

Reuters

14 days ago

Sanofi sheds $13 billion in value on weak trial results for eczema drug

Press Release: Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis
SNY

GlobeNewswire

14 days ago

Press Release: Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis

SNY

MT Newswires

16 days ago

Thermo Fisher Scientific Completes Acquisition of Sanofi's Ridgefield Facility in New Jersey

Sanofi CEO: AI might beat IQ, not EQ — but never say never
SNY

Fortune

16 days ago

Sanofi CEO: AI might beat IQ, not EQ — but never say never

Amgen to invest $600M in new US center; Sanofi drug for ITP approved
SNY

BioPharma Dive

16 days ago

Amgen to invest $600M in new US center; Sanofi drug for ITP approved

Thermo Fisher Scientific Completes Acquisition of Sanofi’s Ridgefield, New Jersey Site
SNY

Business Wire

16 days ago

Thermo Fisher Scientific Completes Acquisition of Sanofi’s Ridgefield, New Jersey Site

SNY

Argus Research

16 days ago

Weekly Stock List

Sanofi Gets FDA Nod for Wayrilz in Immune Thrombocytopenia
SNY

Zacks

16 days ago

Sanofi Gets FDA Nod for Wayrilz in Immune Thrombocytopenia

FDA approves Sanofi’s BTK inhibitor for immune thrombocytopenia
SNY

Pharmaceutical Technology

17 days ago

FDA approves Sanofi’s BTK inhibitor for immune thrombocytopenia

Norfolk Southern Corporation (NSC)’s Merger Could Suffer From CSX CEO’s Belief, Says Jim Cramer
SNY

Insider Monkey

18 days ago

Norfolk Southern Corporation (NSC)’s Merger Could Suffer From CSX CEO’s Belief, Says Jim Cramer

CSX Corporation (CSX)’s CEO Is The “Number One,” Says Jim Cramer
SNY

Insider Monkey

18 days ago

CSX Corporation (CSX)’s CEO Is The “Number One,” Says Jim Cramer

Snowflake Inc. (SNOW) Is A “Tremendous” American Company Doing Incredible Things, Says Jim Cramer
SNY

Insider Monkey

18 days ago

Snowflake Inc. (SNOW) Is A “Tremendous” American Company Doing Incredible Things, Says Jim Cramer

Burlington Stores, Inc. (BURL) Is Just “Unbelievable,” Says Jim Cramer
SNY

Insider Monkey

18 days ago

Burlington Stores, Inc. (BURL) Is Just “Unbelievable,” Says Jim Cramer

The TJX Companies, Inc. (TJX) Has “Extraordinary” Bargains, Says Jim Cramer
SNY

Insider Monkey

18 days ago

The TJX Companies, Inc. (TJX) Has “Extraordinary” Bargains, Says Jim Cramer

Loss-Making Turnium Technology Group Inc. (CVE:TTGI) Expected To Breakeven In The Medium-Term
SNY

Simply Wall St.

18 days ago

Loss-Making Turnium Technology Group Inc. (CVE:TTGI) Expected To Breakeven In The Medium-Term

Analysts Just Shaved Their EHang Holdings Limited (NASDAQ:EH) Forecasts Dramatically
SNY

Simply Wall St.

18 days ago

Analysts Just Shaved Their EHang Holdings Limited (NASDAQ:EH) Forecasts Dramatically

What Is SPX Technologies, Inc.'s (NYSE:SPXC) Share Price Doing?
SNY

Simply Wall St.

18 days ago

What Is SPX Technologies, Inc.'s (NYSE:SPXC) Share Price Doing?

Sanofi (SNY) Expands Pipeline Through Multi-Billion Acquisitions Despite Earnings Miss
SNY

Insider Monkey

18 days ago

Sanofi (SNY) Expands Pipeline Through Multi-Billion Acquisitions Despite Earnings Miss

Press Release: Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia
SNY

GlobeNewswire

19 days ago

Press Release: Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia

Sanofi (SNY)’s Sarclisa Gets EMA Nod for Multiple Myeloma
SNY

Insider Monkey

20 days ago

Sanofi (SNY)’s Sarclisa Gets EMA Nod for Multiple Myeloma

Novavax, Inc. (NVAX) Wins FDA Approval for Nuvaxovid BLA
SNY

Insider Monkey

20 days ago

Novavax, Inc. (NVAX) Wins FDA Approval for Nuvaxovid BLA

Novavax, Inc. (NVAX) Launches Protein-Based Vaccine for High-Risk Adults
SNY

Insider Monkey

21 days ago

Novavax, Inc. (NVAX) Launches Protein-Based Vaccine for High-Risk Adults

Goldman and Citi See European Stock Rally Surviving French Drama
SNY

Bloomberg

21 days ago

Goldman and Citi See European Stock Rally Surviving French Drama

SNY

MT Newswires

21 days ago

Novavax's Nuvaxovid COVID-19 Vaccine Formula Approved by FDA

Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.
SNY

PR Newswire

21 days ago

Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.

Amylyx drug comes up short; Sanofi names new CMO
SNY

BioPharma Dive

22 days ago

Amylyx drug comes up short; Sanofi names new CMO

Dyslipidemia Market Research Report 2025-2035 | Competitive Analysis of Amgen, Sanofi, Regeneron, Pfizer, Novartis, Viatris, AbbVie, AstraZeneca, Horizon Therapeutics, Esperion Therapeutic
SNY

GlobeNewswire

22 days ago

Dyslipidemia Market Research Report 2025-2035 | Competitive Analysis of Amgen, Sanofi, Regeneron, Pfizer, Novartis, Viatris, AbbVie, AstraZeneca, Horizon Therapeutics, Esperion Therapeutic

Chronic Inducible Urticaria (CIndU) Market Research Report 2025-2035 | Competitive Analysis of AstraZeneca, Celldex Therapeutics, J&J, Merck, Novartis, Pfizer, Regeneron Pharma, Sanofi, Sun Pharma
SNY

GlobeNewswire

22 days ago

Chronic Inducible Urticaria (CIndU) Market Research Report 2025-2035 | Competitive Analysis of AstraZeneca, Celldex Therapeutics, J&J, Merck, Novartis, Pfizer, Regeneron Pharma, Sanofi, Sun Pharma

SNY

Argus Research

22 days ago

The Argus High-Yield Model Portfolio

New Report Highlights Community Health Workers' Impact, Calls for Sustained Local Investment, During National CHW Awareness Week
SNY

PR Newswire

22 days ago

New Report Highlights Community Health Workers' Impact, Calls for Sustained Local Investment, During National CHW Awareness Week

Is Now the Right Moment for Sanofi After GSK Lawsuit Settlement in 2025?
SNY

Simply Wall St.

23 days ago

Is Now the Right Moment for Sanofi After GSK Lawsuit Settlement in 2025?

Sanofi (SNY) Receives Orphan Designation for Rilzabrutinib
SNY

Insider Monkey

23 days ago

Sanofi (SNY) Receives Orphan Designation for Rilzabrutinib

[Latest] Global Targeted Drug Delivery Market Size/Share Worth USD 39.6 Billion by 2034 at a 15.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
SNY

GlobeNewswire

24 days ago

[Latest] Global Targeted Drug Delivery Market Size/Share Worth USD 39.6 Billion by 2034 at a 15.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Sanofi (ENXTPA:SAN): Revisiting Valuation as Shares Rebound After Volatile Period
SNY

Simply Wall St.

a month ago

Sanofi (ENXTPA:SAN): Revisiting Valuation as Shares Rebound After Volatile Period

[Latest] Global Biologics and Biosimilars Market Size/Share Worth USD 1,320.19 Billion by 2034 at a 10.42% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
SNY

GlobeNewswire

a month ago

[Latest] Global Biologics and Biosimilars Market Size/Share Worth USD 1,320.19 Billion by 2034 at a 10.42% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Leaders Come Together to Advance the Industry at Veeva Summit
SNY

PR Newswire

a month ago

Leaders Come Together to Advance the Industry at Veeva Summit

SNY

Investing.com

a month ago

BofA downgrades Novavax stock on vaccine uncertainty

SNY

MT Newswires

a month ago

Novavax Faces 'Increasingly Murky' Outlook on Vaccine Uncertainties, BofA Securities Says

SNY

MT Newswires

a month ago

European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

LRN Corporation Wins Seven Brandon Hall Group Awards
SNY

Business Wire

a month ago

LRN Corporation Wins Seven Brandon Hall Group Awards

SNY

MT Newswires

a month ago

European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading

Novavax Strengthens Position with Vaccine Approval and Sanofi Partnership
SNY

Insider Monkey

a month ago

Novavax Strengthens Position with Vaccine Approval and Sanofi Partnership

Beyfortus® (nirsevimab) approved in Singapore to protect all infants against RSV disease
SNY

PR Newswire

a month ago

Beyfortus® (nirsevimab) approved in Singapore to protect all infants against RSV disease

Sanofi: Information concerning the total number of voting rights and shares - July 2025
SNY

GlobeNewswire

a month ago

Sanofi: Information concerning the total number of voting rights and shares - July 2025

Sanofi receives orphan status from EMA for rilzabrutinib
SNY

Pharmaceutical Technology

a month ago

Sanofi receives orphan status from EMA for rilzabrutinib

Sanofi’s Tzield secures MHRA go-ahead for type 1 diabetes
SNY

Pharmaceutical Technology

a month ago

Sanofi’s Tzield secures MHRA go-ahead for type 1 diabetes

SNY's Rilzabrutinib Gets EU Orphan Drug Tag for IgG4-Related Disease
SNY

Zacks

a month ago

SNY's Rilzabrutinib Gets EU Orphan Drug Tag for IgG4-Related Disease

Press Release: Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease
SNY

GlobeNewswire

a month ago

Press Release: Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease

Inhibrx Reports Second Quarter 2025 Financial Results
SNY

PR Newswire

a month ago

Inhibrx Reports Second Quarter 2025 Financial Results

Saudi Arabia Diabetes Drug Market Trends & Forecast Report 2025-2033 | New Therapeutic Agents Like SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Biosimilar Insulins Fueling Growth
SNY

GlobeNewswire

a month ago

Saudi Arabia Diabetes Drug Market Trends & Forecast Report 2025-2033 | New Therapeutic Agents Like SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Biosimilar Insulins Fueling Growth

Saudi Arabia Blood Glucose Device Market Trends and Company Analysis Report 2025-2033 Featuring Abbott Laboratories, Medtronic, Dexcom, Braun, DarioHealth, Sanofi, Bionime, and Novo Nordisk
SNY

GlobeNewswire

a month ago

Saudi Arabia Blood Glucose Device Market Trends and Company Analysis Report 2025-2033 Featuring Abbott Laboratories, Medtronic, Dexcom, Braun, DarioHealth, Sanofi, Bionime, and Novo Nordisk

Adagene Reports Six Months 2025 Financial Results and Provides Corporate Updates
SNY

GlobeNewswire

a month ago

Adagene Reports Six Months 2025 Financial Results and Provides Corporate Updates

Quantified Named to 2025 Inc. 5000, One of the 50 Fastest-Growing AI Firms in the U.S.
SNY

PR Newswire

a month ago

Quantified Named to 2025 Inc. 5000, One of the 50 Fastest-Growing AI Firms in the U.S.

Share on Social Networks: